Delcath Systems to Host Second Quarter 2022 Results

Provided By PR Newswire

Last update: Jul 27, 2022

NEW YORK, July 27, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on August 8, 2022, at 8:30 AM Eastern Time to discuss results for its second quarter ended June 30, 2022.